MentionFox
Home › Layoffs › Kiniksa Pharmaceuticals International, plc
SEC filings · Form 8-K, Item 2.05

Kiniksa Pharmaceuticals International, plc layoffs and restructuring

Before you join, sell to or invest in Kiniksa Pharmaceuticals International, plc

MentionFox check on Kiniksa Pharmaceuticals International, plc: only 2 sources on file so far (checked 15 November 2026). Run a full check before you rely on it. mentionfox.com/c/layoffs/kiniksa-pharmaceuticals-international

  • Note: Layoff plan disclosed Feb 2025 (filing)

New since last check: Layoff plan disclosed Feb 2025 (filing, first seen 14 November 2026).

Check Kiniksa Pharmaceuticals International, plc before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Kiniksa Pharmaceuticals International, plc?

Every exit or restructuring plan Kiniksa Pharmaceuticals International, plc reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

As of November 15, 2026, Kiniksa Pharmaceuticals International, plc has reported one exit or restructuring plan to the SEC on Form 8-K under Item 2.05, the latest filed on February 25, 2025. No WARN notice under its name is on file in the states covered here (Form 8-K, February 25, 2025).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Baker Bros. Advisors LP also filed stake reports on 25 other companies ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of Kiniksa Pharmaceuticals International, plc.

Watch Kiniksa Pharmaceuticals International, plc: email me the next time it files something

Free to see. No signup.

People from Kiniksa Pharmaceuticals International, plc who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the Kiniksa Pharmaceuticals International, plc layoff? Add yourself to the open-to-work list, free
SEC filings1
Latest filing2025-02-25

Kiniksa Pharmaceuticals International, plc reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did Kiniksa Pharmaceuticals International have layoffs in 2025? What its filings say

Kiniksa Pharmaceuticals International, plc (CIK 1730430) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2025-02-25

Expected charges

As a result of the termination of the Phase 2b clinical trial, the Company has incurred approximately $19 million in expenses and expects to record approximately $14 million to $17 million in additional expenses, almost entirely consisting of expenses related to contract termination costs for the Company's clinical supply agreements for abiprubart, with additional de minimis costs related to trial closeout activities.

Timing

The Company expects to immediately end enrollment and initiate winddown activities for the clinical trial, with full completion of winddown activities expected to occur by the end of 2025.

Also on the record for Kiniksa Pharmaceuticals International, plc

DateRecordFigureOur pageSource
October 22, 2026Leadership change: Ross Moat appointed, Chief Operating Officer—Leadership changesSource
July 29, 2026Stake report, Schedule 13G, by BlackRock, Inc.5.5% of the class5%+ stakesSource
May 26, 2026Stake report, Schedule 13D/A, by Baker Bros. Advisors LP7% of the class5%+ stakesSource
May 6, 2026Stake report, Schedule 13G/A, by FMR LLC14.8% of the class5%+ stakesSource
May 1, 2026Leadership change: Eben Tessari departs, Chief Strategy Officer, and 1 more—Leadership changesSource
March 27, 2026Stake report, Schedule 13G/A, by The Vanguard Group—5%+ stakesSource
March 6, 2026Stake report, Schedule 13G, by FMR LLC10.6% of the class5%+ stakesSource
February 13, 2026Stake report, Schedule 13G/A, by Rubric Capital Management LP7.37% of the class5%+ stakesSource
January 14, 2026Leadership change: Ross Moat appointed, Chief Operating Officer, and 1 more—Leadership changesSource
October 31, 2025Stake report, Schedule 13G/A, by The Vanguard Group7.04% of the class5%+ stakesSource
July 17, 2025Stake report, Schedule 13G/A, by BlackRock, Inc.1% of the class5%+ stakesSource
July 9, 2025Stake report, Schedule 13G/A, by RUBRIC CAPITAL MANAGEMENT LP9.24% of the class5%+ stakesSource

Keep reading

More on Kiniksa Pharmaceuticals International, plc and the records around it.

Kiniksa Pharmaceuticals International, plc elsewhere on the record

Companies that share a holder

What do you want to do with Kiniksa Pharmaceuticals International, plc?

Want the whole picture on Kiniksa Pharmaceuticals International, plc?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Kiniksa Pharmaceuticals International, plc: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Kiniksa Pharmaceuticals International, plc covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Tools for this story

Each opens in a new tab, filled in for Kiniksa Pharmaceuticals International, plc. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/kiniksa-pharmaceuticals-international
Last updated 2026-11-15
Kiniksa Pharmaceuticals International, plc layoffs and restructuring: 1 SEC filing (2025-02-25). MentionFox, 2026-11-15. https://mentionfox.com/layoffs/kiniksa-pharmaceuticals-international